GCM
ALT icon

Graham Capital Management’s Altimmune ALT Stock Holding History

Graham Capital Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$137K Buy
+44,940
New +$134K ﹤0.01% 1108
2023
Q4 		– Sell
-94,105
Closed -$245K – 981
2023
Q3 		$245K Sell
94,105
-49,324
-34% -$142K 0.01% 794
2023
Q2 		$506K Buy
+143,429
New +$644K 0.01% 552
2022
Q2 		– Sell
-10,345
Closed -$63K – 983
2022
Q1 		$63K Buy
+10,345
New +$76.2K ﹤0.01% 869

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Graham Capital Management's ALT Position: Q2 2026 in Review

Graham Capital Management opened a new position in Altimmune (ALT) in Q2 2026: 44,940 shares worth $137K. The stake represents ﹤0.01% of the portfolio and ranks #1108 among its holdings. This is a return to the name: Graham Capital Management previously reported a position in ALT as recently as Q3 2023.

Graham Capital Management first reported a position in ALT in Q1 2022 and has held it in 4 quarters since. The position peaked at $506K in Q2 2023. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Graham Capital Management held 44,940 shares of Altimmune worth $137K as of Q2 2026.
  • Altimmune was a new Graham Capital Management position in Q2 2026.
  • Altimmune made up ﹤0.01% of Graham Capital Management's portfolio in Q2 2026, its #1108 holding.
  • Graham Capital Management first reported a position in Altimmune in Q1 2022 and has held it in 4 quarters since.
  • Graham Capital Management's Altimmune position peaked at $506K in Q2 2023.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.